WILMINGTON, Del.--(BUSINESS WIRE)--Nov 3, 2023--Combination of zibotentan with dapagliflozin showed statistically significant and clinically meaningful reductions in urinary albumin-to-creatinine ratio (UACR), used to assess albuminuria, at 12 weeks compared with dapagliflozin alone.After 12 ...
WATERTOWN, Mass.--(BUSINESS WIRE)--Nov 3, 2023--<a ...
FINDLAY, Ohio (AP) 鈥� Communities ravaged by America蘑菇视频 opioid epidemic are starting to get their share of a $50 billion pie from legal settlements.Most of that money comes with a requirement that it be used to address the overdose crisis and prevent more deaths.But how?It could mean that ...
DUBLIN--(BUSINESS WIRE)--Nov 3, 2023--The <a ...
ROCKVILLE, Md.--(BUSINESS WIRE)--Nov 3, 2023--GlycoMimetics, Inc. (Nasdaq: GLYC), a late clinical-stage biotechnology company discovering and developing glycobiology-based therapies for cancers and inflammatory diseases, today reported its financial results and highlights for the third quarter ...
MARSEILLE, France--(BUSINESS WIRE)--Nov 3, 2023--Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (鈥� <em>Innate</em> 鈥� or the 鈥� <em>Company</em> 鈥�) today announced that several abstracts, including one oral presentation, have ...
